Authors:
Dey, BR
McAfee, S
Sackstein, R
Colby, C
Saidman, S
Weymouth, D
Poliquin, C
Vanderklish, J
Sachs, DH
Sykes, M
Spitzer, TR
Citation: Br. Dey et al., Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation, BIOL BLOOD, 7(11), 2001, pp. 604-612
Authors:
Buhler, L
Goepfert, C
Kitamura, H
Basker, M
Gojo, S
Alwayn, IPJ
Chang, Q
Downs, JD
Tsai, H
Wise, R
Sachs, DH
Cooper, DKC
Robson, SC
Sackstein, R
Citation: L. Buhler et al., Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy, BONE MAR TR, 27(12), 2001, pp. 1227-1236
Authors:
Alwayn, IPJ
Buhler, L
Appel, JZ
Goepfert, C
Csizmadia, E
Correa, L
Harper, D
Kitamura, H
Down, J
Awwad, M
Sackstein, R
Cooper, DKC
Robson, SC
Citation: Ipj. Alwayn et al., Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation, TRANSPLANT, 71(11), 2001, pp. 1601-1609
Authors:
Gonzalez, S
Sackstein, R
Anderson, RR
Rajadhyaksha, M
Citation: S. Gonzalez et al., Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy, J INVES DER, 117(2), 2001, pp. 384-386
Authors:
Exley, MA
Tahir, SMA
Cheng, O
Shaulov, A
Joyce, R
Avigan, D
Sackstein, R
Balk, SP
Citation: Ma. Exley et al., Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses, J IMMUNOL, 167(10), 2001, pp. 5531-5534
Authors:
Spitzer, TR
McAfee, S
Sackstein, R
Colby, C
Multani, P
Saidman, S
Weymouth, D
Preffer, F
Poliquin, C
Foley, A
Cox, B
Andrews, D
Sachs, DH
Sykes, M
Citation: Tr. Spitzer et al., Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies, BIOL BLOOD, 6(3A), 2000, pp. 309-320
Authors:
Toh, HC
McAfee, SL
Sackstein, R
Multani, P
Cox, BF
Garcia-Carbonero, R
Colby, C
Spitzer, TR
Citation: Hc. Toh et al., High-dose cyclophosphamide plus carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study, BONE MAR TR, 25(1), 2000, pp. 19-24
Authors:
Gopfert, C
Buhler, L
Wise, R
Basker, M
Gojo, S
Imai, M
Alwayn, I
Sachs, DH
Sackstein, R
Cooper, DKC
Robson, SC
Citation: C. Gopfert et al., Von Willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation, TRANSPLAN P, 32(5), 2000, pp. 990-990
Authors:
Alwayn, IPJ
Buhler, L
Basker, M
Goepfert, C
Kawai, T
Kozlowski, T
Ierino, F
Sachs, DH
Sackstein, R
Robson, SC
Cooper, DKC
Citation: Ipj. Alwayn et al., Coagulation/thrombotic disorders associated with organ and cell xenotransplantation, TRANSPLAN P, 32(5), 2000, pp. 1099-1099
Authors:
Buhler, L
Awwad, M
Basker, M
Gojo, S
Thall, A
Down, JD
Sykes, M
Andrews, D
Sackstein, R
White-Scharf, ME
Sachs, DH
Cooper, DKC
Citation: L. Buhler et al., A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons, TRANSPLAN P, 32(5), 2000, pp. 1100-1100
Authors:
Buhler, L
Basker, M
Alwayn, IPJ
Goepfert, C
Kitamura, H
Kawai, T
Gojo, S
Kozlowski, T
Ierino, FL
Awwad, M
Sachs, DH
Sackstein, R
Robson, SC
Cooper, DKC
Citation: L. Buhler et al., Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates, TRANSPLANT, 70(9), 2000, pp. 1323-1331
Authors:
Buhler, L
Awwad, M
Basker, M
Gojo, S
Watts, A
Treter, S
Nash, K
Oravec, G
Chang, Q
Thall, A
Down, JD
Sykes, M
Andrews, D
Sackstein, R
White-Scharf, ME
Sachs, DH
Cooper, DKC
Citation: L. Buhler et al., High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response, TRANSPLANT, 69(11), 2000, pp. 2296-2304
Authors:
Colby, C
Chang, Q
Fuchimoto, Y
Ferrara, V
Murphy, M
Sackstein, R
Spitzer, TR
White-Scharf, ME
Sachs, DH
Citation: C. Colby et al., Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine, TRANSPLANT, 69(1), 2000, pp. 135-140
Authors:
Dimitroff, CJ
Lee, JY
Fuhlbrigge, RC
Sackstein, R
Citation: Cj. Dimitroff et al., A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells, P NAS US, 97(25), 2000, pp. 13841-13846
Citation: R. Sackstein et Cj. Dimitroff, A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity, BLOOD, 96(8), 2000, pp. 2665-2674
Citation: R. Sackstein et Cj. Dimitroff, A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity, BLOOD, 96(8), 2000, pp. 2765-2774
Authors:
Toh, HC
McAfee, SL
Sackstein, R
Cox, BF
Colby, C
Spitzer, TR
Citation: Hc. Toh et al., Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation, BONE MAR TR, 24(8), 1999, pp. 891-895
Authors:
Colby, C
McAfee, SL
Sackstein, R
Finkelstein, DM
Fishman, JA
Spitzer, TR
Citation: C. Colby et al., A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation, BONE MAR TR, 24(8), 1999, pp. 897-902
Authors:
Sykes, M
Preffer, F
McAfee, S
Saidman, SL
Weymouth, D
Andrews, DM
Colby, C
Sackstein, R
Sachs, DH
Spitzer, TR
Citation: M. Sykes et al., Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects afternon-myeloablative therapy and HLA-mismatched bone-marrow transplantation, LANCET, 353(9166), 1999, pp. 1755-1759
Authors:
Salgia, R
Quackenbush, E
Lin, J
Souchkova, N
Sattler, M
Ewaniuk, DS
Klucher, KM
Daley, GQ
Kraeft, SK
Sackstein, R
Alyea, EP
von Andrian, UH
Chen, LB
Gutierrez-Ramos, JC
Pendergast, AM
Griffin, JD
Citation: R. Salgia et al., The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1 alpha, BLOOD, 94(12), 1999, pp. 4233-4246